| Application no. and date | 13182721.4 (espacenet) (Federated) (European Patent Register), 20090514 | | Patent/reg. no. and date | DK/EP 2695609, 20191211 | | Publication date | 20140212 | | Priority no. and date | US 53609 P, 20080515, US 201145 P, 20081205, US 157875 P, 20090305 | | EP pub. no. and date |
EP 2695609 20140212 | | Effective date | | | Applicant/owner | Celgene Corporation, Route 206 & Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | P70685DK01 | | Inventor | LAI, Mei, 1038 Neon Forest Circle
Longmont, CO 80504, US,
Etter, Jeffrey B., 1318 Deer Train Rd.
Boulder, CO 80302, US,
Backstrom, Jay T., 15400 Aberdeen St.
Leawood, KS 66224, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) | | Title | Orale formuleringer af cytidinanaloger og fremgangsmåder til anvendelse deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
